
Carrier-Free Silibinin/Sorafenib Microparticles Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease by ...
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most prevalent chronic liver condition globally, affecting approximately 38% of the population.1,2 Its incidence continues to rise due to changes in lifestyle and diet, …